← Back to Dashboard

Raloxifene

Selective estrogen receptor modulator

2D Structure

Loading structure...

3D Structure

Loading 3D structure...

Chemical Identifiers

C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O
GZUITABIAKMVPG-UHFFFAOYSA-N
ClinicalTrials.govPubMed

Clinical Development by Virus13

Zaire ebolavirus
EBOV
Target: Human (multiple)
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:23785035
Dengue virus
DENV-2
Target: Human (multiple)
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:30791609
Human immunodeficiency virus 1
HIV-1
Target: Human (multiple)
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:30791609
Human alphaherpesvirus 1
HSV-1
Target: Human (multiple)
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:30791609
Rabies lyssavirus
RABV
Target: Human (multiple)
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:30791609
Sindbis virus
SINV
Target: Human (multiple)
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:30791609
Vaccinia virus
VACV
Target: Human (multiple)
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:30791609
Indiana vesiculovirus
VSV
Target: Human (multiple)
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:30791609
Yellow fever virus
YFV
Target: Human (multiple)
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:30791609
African swine fever virus
ASFV
Target: Human (multiple)
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:33249093
Human coronavirus 229E
HCoV-229E
Target: Human (multiple)
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:33249093
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:33249093
Lujo mammarenavirus
LUJV
Target: Human (multiple)
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:34203149